Magic mushroom compound tested for cancer pain relief

This phase II trial tests whether low-dose psilocybin, a compound from magic mushrooms, combined with psychotherapy is safe and effective for easing chronic pain in cancer patients who already take opioids. Twenty adults with active cancer and moderate to severe pain will receive psilocybin and talk therapy. The study focuses on safety and pain reduction, aiming to address the physical, emotional, and spiritual aspects of pain.